George Letson
Tampa, FLNPI 1043280142
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $462,948 of the $682,149 with a category attached, or 67.9%. Stryker accounts for 99.9% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $370,851, 9.6 times the $38,826 reported in 2019.
Across 217 payments — averaging $3143.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$682K
- Onkos Surgical, Inc.$165
- Zimmer Biomet$101
- Baxter Healthcare$89
What the payments were for
- Royalty or licence$462,94868%
- Consulting fees$194,37528%
- Speaking & faculty fees$1,5000%
- Travel & lodging$19,1143%
- Food & beverage$4,2121%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 213 | $681,794 |
| Onkos Surgical, Inc. | 2 | $165 |
| Zimmer Biomet | 1 | $101 |
| Baxter Healthcare | 1 | $89 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.